Ana Santos Rutschman

Vaccines as Technology (eBook, PDF)

Innovation, Barriers, and the Public Health

• Format: PDF

Produktbeschreibung

The COVID-19 pandemic served as a powerful wake-up call, highlighting our collective need for the effective development and equitable distribution of new vaccines, in addition to widespread administration of existing ones. The current models of production and allocation of vaccines against emerging pathogens, which rely on predominantly market-driven mechanisms, are largely at odds with public health needs. This book is the first to explore the entire arc of vaccine development and distribution, from the decisions about allocation of vaccine R&D money to allocation and administration of vaccines resulting from the R&D process. It explains key concepts and problems in vaccine regulation, intellectual property, technology transfer, and international relations, making complex material accessible to a non-specialist audience. Analyzing the impact of COVID-19, the book also covers several other vaccine races, as well as future directions in vaccine development and allocation.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Cambridge University Press
• Erscheinungstermin: 14. April 2022
• Englisch
• ISBN-13: 9781009275552
• Artikelnr.: 66177672

Autorenporträt

Ana Santos Rutschman is outgoing Assistant Professor of law Saint Louis University and incoming Professor of Law at Villanova University. She was named a Health Law Scholar (2018) and a Bio Intellectual Property Scholar (2017) by the American Society of Law, Medicine & Ethics for her work on vaccine law and policy.

Inhaltsangabe

Introduction
1. Vaccines as instruments of public health
2. The vaccine development ecosystem
3. Vaccine development under proprietary paradigms
4. Access to vaccine technology
5. Aligning vaccine innovation with public health needs
6. Vaccines of the future: present and emerging challenges
Conclusion: broader implications for global public health.